Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
GLY-200, an oral pharmacologic duodenal exclusion drug, resulted in positive effects on glucose, lipids and bodyweight in patients with type 2 diabetes: Results of a randomized, double-blind placebo-controlled trial.
Journal: Diabetes, obesity & metabolism
Published: April 28, 2025
Adipose tissue measurement in clinical research for obesity, type 2 diabetes and NAFLD/NASH.
Journal: Endocrinology, diabetes & metabolism
Published: December 16, 2021
Showing 1-2 of 2
Last Updated: 09/26/2026